It's been a mediocre week for Omnicell, Inc. (NASDAQ:OMCL) shareholders, with the stock dropping 11% to US$40.16 in the week since its latest annual results. Revenues were US$1.1b, approximately ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...
Omnicell, which belongs to the Zacks Medical Info Systems industry, posted revenues of $306.88 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.35%.
The North Carolina not-for-profit healthcare system selected Omnicell's XT automated cabinets as it seeks to enhance patient-care on nursing floors and in perioperative settings. With our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results